Makin and Trafford: Urinary steroid analysis by semiautomated computerised GLC 899 J. Clin. Chem. Clin. Biochem. Vol. 20,1982, pp. Summary: A simple gas-liquid Chromatographie method for the measurement of some of the major steroids in urine is described. The System uses conventional packed columns, automatic injection and is linked to an integrator. Calculations are all carried out by Computer. The System is recommended äs a simple screening procedure, producing a urinary steroid 'profile', which can process large numbers of urine samples cheaply and quickly, enabling patients worthy of niore intensive investigation to be identified. % 
Introduction
The measurement of urinary 17-oxö-and 17^oxogenic steroids is still carried out in many clinical laboratories by manual cplorimetric methods (1) and these group analyses provide a useful clinical index of adrenocortical function. Plasma steroid assays require venepuncture and concentrations obtäined indicate the endocrine Status at the time of sampling only. Plasma levels of some steroids ündergo rapid pulsatile changes (2) and thüs are liable to considerable errör. Urinary steroid excretion on the other händ f epfesents the integrated seeretion over the period of urine collection and thus provides an arguably better index of endocrine Status. Although accurate 24 h eollections are notoripusly difficult to achieve except under laboratqry conditions, urine colleetiQn is non-invasive, which is of particular significance in young children, and steroid: creatinine ratios have been used in attempts to overcome the difficulties of collection.
Despite ithe advantages of urine steroid assays they have largely been supplanted by the advent of radioimmunoassays for plasma steroids. But there would still seem to be a place for urinary steroid analysis -particularly for multi-component or "p r°f fl e " analysis (3, 4) . Shackleton (4) advocates the use of a capillary gas-liquid Chromatographie System (5) for this purpose, using SepPak cartridges för extraction and suggests that such a System is within the capabilities of many clinical laboratories.
Capillary column GLC ist not easy to operate or Interpret and, in our view, should not be regarded äs a routine System for the analysis of urinary steroids, although it is however a very valuable technique and certainly has a place in the detailed investigation and characterisation of those patients shown to have endocrine abnormalities, such äs congenital adrenal > 6 1 $ (6) or placental sulphatase deficiency (7) . We would advocate the prior use of a simpler screening procedure which can process large numbers of samples more > quickly and cheaply than is possible using capillary GLC, allpwing the detection of those patients in whom a more exacting examination, such äs that described by Shackleton (4) , is required. To that end we describe here a semi-automated computerised gas-liquid Chromatographie System, using conventional packed columns.
0340-076X/82/0020-0899$02. 00 This System has been in routine use at the London Hospital for nearly 10 years äs a screening procedure for the investigation of patients with suspected adrenocortical dysfunction. This procedure measures the major 17-oxo-, 17-oxogenic and othermajor steroid metabolites present in human urine.
Materials and Methods

Reagents
Reagents used were all Analytical Reagent grade from BDH Chemicals Ltd. Poole, Dorset, UK if available -otherwise the highest grade reagent was obtained and purified by distillation prior to use. Methylene Chloride was tested before use by evaporating 50 ml to dryness and chromatographing l/20th of the final extract, examining for the presence of dibutyl or dioctyl phthalates -the latter has the same retention time äs aetiocholanolane formate in the GLC System used. Batches of methylene Chloride with high concentrations of phthalates present were returned to the suppliers or redistilled before use. Other reagents used were äs described by Trafford & Makin (S) . Steroid formate esters are particularly susceptible to absorption and/or destruction on the 'inert' support of the stationary phase (9) . Most commercially available Supports were found to vary considerably and were seldom adequate for use with steroid formates. Column packing materials were therefore prepared by coating inactivated Celite 545 (100/200 mesh, Phase Separations Ltd., Queensferry, Flintshire, UK) with 1-2% OVI (Phase Separations Ltd.) by treating 50g of inactivated Celite 545 with 100 ml of 1-2% solution öf OV1 in toluene, using the filtration method described by Supina (10).
Celite was inactivated by Standing for 7 days in 50% (v/v) concentrated hydrochloric acid and then washed to neutrality with distilled water, discarding fines at each wash. After drying in a vacuum oven for 48 h at 37 °C, the Celite was flushed with oxygen-free nitrogen for 24 hours. After this period, dimethyldichlorosilane solution (10 ml/l in toluene) was added, the slurry degassed and filled with nitrogen. After l hour, the dimethyldichlorosilane solution was removed using a Büchner illter, and the Celite re-suspended in methanoi thiee times and fmally dried at 37 °C in a vacuum oven for 24 hours. Only if this procedure was carefuUy followed was consistent quality packing material obtained. A crucial Step was found to be the rigorous exclusion of oxygen prior to and during the 'süanisation' proeedure. GLC columns were themselves 'sflanised* by treatment with 10 ml/1 dimethyldichlorosilane, in'toluene, washed with methanol and dried prior to fdling with the packing material (approx. 7 g per cplumn, 2.1 m X 0.4 cm ID). Each column was connected to the carrier gas (nitrogen) at room temperature and the column gassed for 10 min to exclude oxygen. The column was then heated with no carrier gas flpw for l hpur at 300 °C. After cpoling the carrier gas flow was resumed and the column cpnditioned by heating for 12 hours at its maximum operating temperature. Columns were tested before use by injecting 0.1 and 1.0 of a mixture of Standard steroid formates. The response factörs öf each component of the mixture in relation to the internal Standards should be the same whatever volume is injected. table l gives a list of the steroid used in this Standard mixture together with the typical respoiise factörs obtained on a satisfactory colümii. 11/Hiydroxyaetiocholanolone formate, having a sterically hindered, and thus unesteri* fied, 11/3-hydroxyl, is particularly susceptible to absorption. Figure l indicates the Variation of tue response factor for 110* hydroxyaetiochplanolone with volurne injected using an unsatisfactory column showing absorption and a satisfactory column. Columns which have been in use for spme time begin to shpw selective absorption of il-hydroxy steroids which can occasionally be overcome in the shört-term by the injection of water. However the best solution is either to replace the column pr to re-pack the first 10 cm of column packing with fresh material.
Method
The chemical procedures used prior to GLC analysis were generally äs described by Trafford & Makin (8) and are outlined in table 2 except that sodium metaperiodäte oxidatiori was earried out in 0.1 mol/1 phosphate buffer, pH 6.0 and methylene dichloride extracts were washed with 5% (v/v) hydrochlorie acid after the NaOH wash. This extra wash was found to be necessary to remove basic drug metabolites which öccäsionally interfered in the GLC analysis -for example propranolol (8) and trl· methoprim (a component of Septrin). Extraction with methylene Tab. 1. Composition of a typical Standard steroid formate mixture.
Steroid formate 5a-Androstan-17-one (Standard 1) 50-Androstan-3a-ol-l 7-one 5a-Androstan-3a-ol-1 7-one 5j3-Androstane-3a, 1 7a-diol 5/3-Androstane-3a, 1 7a-diol 5|3-Andro'stane-3a,l 1/3-diol-l 7-one 5a-Androstane-3a,l 10-diol-l 7-one 5|3-Pregane-3a,20a-diol diacetate (Standard 2) Cholesterol 50-Androstane-3a,l Ij3,17a-triol 5oi-Androstane-3a, Steroids present in urine after borohydride reduction and periodate oxidation (äs described in the text) were extracted with dichloromethane for varying times, after addition of an internal Standard (5a-androstan-17-one). The extracts were evaporated to dryness, esterified with formic acid and analysed by GLC. Water, to which a mixture of 110-hydroxyaetiocholanolo'ne and 5a-androstan-17-one) had been added, was similarly treated. The change in the ratio 110-hydroxyaetiocholanolone/5o£-androstan-17-one is expressed äs a percentage of the final ratio.
chloride was carried out on an automatic shaker for at least 5 minutes, since investigations showed that a short period of shaking did not extract all steroids to the same degree -an example of this is illustrated in flgure 2. In addition care has to be taken when evaporating sorvents under nitrogen flow at 37 °C since some steroids (notably 5a-androstan-17-one, used äs one of the internal Standards) aie slightly volatile and excessive incubation, when dry, leads to evaporation of steroid. Only incubation of dried extracts with formic acid vappur has been found to form formate esters quarititatively without destruction on all non-sterically hindered groups so far studied. Figure 3 shows the esterification of the 3-hydroxyl group of aetiocholanolone and 110-hydioxyaetiocholanolone.
Tab.
2. An outline of the manual chemistry prior to gas-liquid chromatography.
1. Reduction of oxo groups to corresponding alcohols with sodium borohydride (15 min at 50 °C). . dichloride (at least 2 min shaking). 5. Esterification of dried residues with formic acid vapour at80°C(atieastlh).
Time for processing (in batches of 12 samples): 2.5 h. Since oxo groups are reduced and side chains removed by this chemistry, information about the original metabolites can be lost (i.e. it does not distinguish between 5/3-pregnanetriol and 5/3-tetrahydro Reichenstein S äs precursors of aetiocholanolone formate).
Gas-liquid chromatography was carried out using an F 30 gas Chromatograph and flame ionisation detection, injecting samples using an AS41 injection System (Perkin-Elmer Ltd., Beaconsfield, Bucks., UiK). This injection System, which has a capacity of up to 100 samples uses small aluminium capsules into which the sample is loaded (maximum sample volume is around 20 selected. In the System chosen, GLC was carried out with nitrogen flow rate of about 40 ml/min, usually with a starting temperature of around 215 °C rising at l °C/min to a maximum at 265 °C. Since different batches of column packing material varied slightly, these temperature settings had to be changed from time to time in order to obtain a retention time for 5a-androstan-17-one of approximately 480 s. However each run took 50 minutes, rising at l °C/min from minimum to maximum temperature settings. The AS 41 automatic injection System has the considerable advantage that the whole sample in each capsule is not injected onto the column, thus prolonging column life. Using this injection System, columns need replacing on average after l year of continuous use. Each capsule is pierced by a hollow needle, through which pre-heated carrier gas passes, and volatile Contents of the capsule are flushed onto the column, leaving the non-volatile components, which usually collect on the top of the column, behind in the capsule, which is then rejected. The FID amplüler Output was connected to an Autolab System IV digital Integrator (Spectra-Physics Ltd., St. Albans, Herts, UK), although, of course, any comparable integrator would be suitable. The Output from the Integrator was recorded on a teletype (Olivetti type Te 300, British Olivetti Ltd., London Wl. ÜK) and on 8 hole ASCII punched type (the DATA tape). In a given batch of analyses, the first injection was a mixture of Standards, the composition of which is given in table l, in order to establish the FID response factors for the next four urine extracts, after which another Standard was injected and response factors updated for the next four urine extracts. This sequence of Standards and urine extracts was followed throughout the batch. When the batch was complete, another tape, the PARAMETER tape, was generated by hand in answer to specific questions, givön in figure 4 , which enables the Computer to identify Standards, urine extracts and other details requiied to produce a printout of each patient's results ready for reporting to the consultant who requested the analysis. This second tape, apart from giving details of patient identification, also gives retention time Windows which are required for peäk Identification. Figure 5 outlines the System described above. An outline of the Computer calculations used is given in figure 6 . These calculations are relatively simple and can obviously be carried out on simple microprocessors which could be installed in the laboratory. The system described here is one approach to the problem, which was designed to fit within the constiaints of the local Situation at the London Hospital. Obviously the solution adopted here should not be regarded äs ideal and t hose with access to better Computer Systems could adapt and improve the principle described here. 
Results and Discussion
The system described here has now been in routine Operation at the London Hospital for nearly ten years and has replaced other urinary steroid assays usually requested, 17-oxosteroids, 17-oxogeriicsterqids, pregnanediol, pregnanetriol, 11 oxygenation index, etc., all of which are now provided in a single assay. This system is now pffered äs a Service in the North East Thames Region and for the last five years has been used routinely by St. Bartholomew's Hospital. No special problems have been encountered and i t has coped very successfully with the role assigned to ita simple and rapid screening procedure, enabling the identifieation of patients worthy of further study. The identification of GLC peaks by their retention times is unreliable and can lead to difficulties. However, apart from the two cases mentioned above, propranolol and trimsthoprim, we do not believe that we have misidentified any peak. Scanning peaks in the rnass spectrometer has always given the expected mass spectrum. In some cases odd profiles have been encountered, such äs the one illustrated in figure 7 , which indicates the presence In cases where peaks cannot be identified, a response factor of 1.000 is used. '' · -· * Since retention time for ST2 changes throughout a batch run, a further test is applied to identify ST2. If there is no peak with the precise retention time, the peak-with the nearest retention time plus the two peaks on either side are used. RRTs are calculated using each of the three peaks separately. Using the RRT Windows on the parameter tape, other steroids are identified. The peak which allows the Identification of the largest number of peaks is taken äs ST2. ST2 retention time is updated after every Standard run.
of Cso-aldehydes, presumably derived by side chain oxidation of tetrahydroreduced metabplites of 11-deoxycorticosterone. Dürüig pregnancy, large amounts of 6a-hydroxylated progesterone metabolites are excreted in urine, and this GLC system also measures these steroids äs well. Figure 8 shows a steroid profile from a woman in the last trimester of pregnancy.
Recoveries of added steroids, normal ranges and reproducibility studies have already been reported by Trafford & Makin (8) in their study of the manual method and, using this semi-automated procedure, give similar results. Quality control is maintained by running a Standard urine sample in every bätch -values for precision äre given in table 3.
The procedure described here describes an application of gas-liquid chromatography, which illustrates 1he potentiTab. 3. Reproducibiüty studies.
(a) Inter-assay (n = 10) mg/24 h (b) Intra-assay*) 5a-Androstane-3a,17ardiol 2.98 ± 0.21 5.87 ± 0.33 CV 50rAndrostan-3a-ol-l 7?pne 5^-Andrpstane-3a,l 7a-diol 5a-Androstane-3a, 17a-diol 5ß-Androstane^3a , 1 Iß^diol·! 7^one 5a-Androstane-3a , 1 1/3-diol-l 7-one 5^Androstane-3ä , Urinary steroid profile from a young child on 11-deoxycorticosterone acetate. The peak marked *X' was identified by mass spectrometry äs the formate ester of 21-nor-50-pregnan-£-ol-20-aL Peaks (formate esters) are identified frpm theii relative retention times äs follows: 1 = 5a-androstan-17-one (Standard 1) 2 = 50-androstan-3a-ol-17-one 3 = 5a-androstan-3a-ol-17-one 4 = 50-androstane-3a,17a-diol 5 = 5a-androstane-3a,17a-diol 6 = 5^androstane-3a,llß-diol-17-one 7 = 5a-androstane-3a,llß-diol-17-one 8 = 50-pregnane-3a,20a-diol 9 = 50*pregnane-3a,20a-diol diacetate (Standard 2) 10 = Cholesterol Fig. 8 . Urinary steroid profile from a pregnant woman just prior to parturition. Peaks (steroid formates) are tentively identified by their relative retention times; 1 = 5a-androstan-17-one (Standard 1) 2 = 5/3-androstan-3a-ol-17-one 3 = 50-androstane-3a,17a-diol 4 = 5a-androstane-3a,17üKÜol 5 = 50-androstane-3a,110-diol-17-one 6 = 5a-androstane^3a,ll|8-diol-17-one 7 = 50-pregnane-3a,20a-diol 8 = 5a-pregnane-3a,20a-diol 9 = 50-pregnane-3a,20a-diol diacetate (Standard 2) 10 = 6a-hydroxy-50-pregnane-3a-diol (associated with an unknown peak). 11 = 6od-hydroxy-5a-pregnane-3a,20a-diol 12 = Cholesterol ality for the production of 'profiles' of closely allied compounds present in human urine which because they constitute a pattem, give more information in a single assay than the estimation of a single compound present in plasma at a gjven time.
